Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis - Forschungsportal der Justus-Liebig-Universität Gießen:

Meeting Abstract

Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis

Autorenliste: Arnold, Michael; Khanna, Dinesh; Denton, Christopher; Lin, Celia; van Laar, Jacob; Frech, Tracy; Anderson, Marina; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Allanore, Yannick; Riemekasten, Gabriela; Steen, Virginia; Mueller-Ladner, Ulf; Spotswood, Helen; Burke, Laura; Siegel, Jeffrey; Jahreis, Angelika; Furst, Daniel; Pope, Janet

Jahr der Veröffentlichung: 2017

Seiten: 881-881

Zeitschrift: The Journal of Rheumatology

Bandnummer: 44

Heftnummer: 6

ISSN: 0315-162X

eISSN: 1499-2752

Konferenz: 72nd Annual Meeting of the Canadian-Rheumatology-Association (CRA)

Verlag: The Journal of Rheumatology

Zitierstile

Harvard-Zitierstil: Arnold, M., Khanna, D., Denton, C., Lin, C., van Laar, J., Frech, T., et al. (2017) Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis, The Journal of Rheumatology, 44(6), p. 881

APA-Zitierstil: Arnold, M., Khanna, D., Denton, C., Lin, C., van Laar, J., Frech, T., Anderson, M., Baron, M., Chung, L., Fierlbeck, G., Allanore, Y., Riemekasten, G., Steen, V., Mueller-Ladner, U., Spotswood, H., Burke, L., Siegel, J., Jahreis, A., Furst, D., ...Pope, J. (2017). Patient Centered Approach to Disease Modification in Scleroderma: Results from the faSScinate Trial of Tocilizumab Compared to Placebo in Active Diffuse Cutaneous Systemic Sclerosis. The Journal of Rheumatology. 44(6), 881.